Moreover, the administration of Bifidobacterium infantis 35624 to 48 ME/CFS cases confirmed the ability of probiotics to reduce the systemic pro-inflammatory markers CRP, TNF-α and IL-6 [128]. This evidence concerns the gene CRP and myalgic encephalomeyelitis/chronic fatigue syndrome.